← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Auna S.A. (AUNA) 10-Year Financial Performance & Capital Metrics

AUNA • • Industrial / General
HealthcareHealthcare FacilitiesHospital & Acute Care FacilitiesGeneral Acute Care Hospitals
AboutAuna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Show more
  • Revenue $4.4B +14.5%
  • EBITDA $928M +20.5%
  • Net Income $111M +143.9%
  • EPS (Diluted) 1.63 +128.2%
  • Gross Margin 37.18% +7.4%
  • EBITDA Margin 21.08% +5.3%
  • Operating Margin 16.08% +15.4%
  • Net Margin 2.51% +138.4%
  • ROE 6.51% +143.1%
  • ROIC 10.01% +28.5%
  • Debt/Equity 2.32 +5.2%
  • Interest Coverage 1.46 +46.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 26.0%
  • ✓Trading at only 0.2x book value

✗Weaknesses

  • ✗High debt to equity ratio of 2.3x
  • ✗Weak momentum: RS Rating 16 (bottom 16%)
  • ✗Shares diluted 54.0% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y26.04%
3Y30.78%
TTM-2.76%

Profit (Net Income) CAGR

10Y-
5Y8.75%
3Y-
TTM252.33%

EPS CAGR

10Y-
5Y-0.72%
3Y-
TTM173.58%

ROCE

10Y Avg10%
5Y Avg8.68%
3Y Avg10.67%
Latest12.72%

Peer Comparison

General Acute Care Hospitals
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
HCAHCA Healthcare, Inc.110.4B483.8021.998.67%8.57%7.13%5.11%81.51
UHSUniversal Health Services, Inc.11.28B204.1912.1410.82%8.09%18.85%9.96%0.73
THCTenet Healthcare Corporation17.69B201.326.160.57%6.49%15.56%6.31%1.68
ARDTArdent Health Partners, LLC1.27B8.905.6310.29%3.24%12.57%10.01%1.50
AUNAAuna S.A.138.14M4.592.8214.47%4.33%10.05%100%2.32
CYHCommunity Health Systems, Inc.462.66M3.34-0.861.15%2.6%25.94%

Profit & Loss

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+719.27M881.61M1.38B1.49B1.97B2.44B3.85B4.4B
Revenue Growth %-0.23%0.57%0.07%0.32%0.24%0.58%0.14%
Cost of Goods Sold+430.14M516.09M860.29M959.2M1.29B1.6B2.52B2.77B
COGS % of Revenue0.6%0.59%0.62%0.65%0.65%0.66%0.65%0.63%
Gross Profit+289.13M365.52M524.13M527.74M682.26M836.88M1.33B1.64B
Gross Margin %0.4%0.41%0.38%0.35%0.35%0.34%0.35%0.37%
Gross Profit Growth %-0.26%0.43%0.01%0.29%0.23%0.59%0.23%
Operating Expenses+232.96M270.4M360.75M417.69M579.05M593.21M795.51M929.29M
OpEx % of Revenue0.32%0.31%0.26%0.28%0.29%0.24%0.21%0.21%
Selling, General & Admin232.96M270.96M360.86M417.9M579.09M593.23M795.51M929.29M
SG&A % of Revenue0.32%0.31%0.26%0.28%0.29%0.24%0.21%0.21%
Research & Development00000000
R&D % of Revenue--------
Other Operating Expenses0561.98K107.14K211.13K45.02K19.9K00
Operating Income+56.18M95.13M163.38M110.05M103.21M243.67M536.04M708.17M
Operating Margin %0.08%0.11%0.12%0.07%0.05%0.1%0.14%0.16%
Operating Income Growth %-0.69%0.72%-0.33%-0.06%1.36%1.2%0.32%
EBITDA+86.03M127.92M220.2M176.69M182.42M381.17M770.04M928.2M
EBITDA Margin %0.12%0.15%0.16%0.12%0.09%0.16%0.2%0.21%
EBITDA Growth %-0.49%0.72%-0.2%0.03%1.09%1.02%0.21%
D&A (Non-Cash Add-back)29.85M32.79M56.82M66.63M79.21M137.5M234M220.03M
EBIT59.79M77.91M166.25M48.81M95.88M163.85M489.5M708.09M
Net Interest Income+-22.31M-20.79M-51.95M-61.63M-94.13M-201.61M-606.5M-508.75M
Interest Income1.05M630K1.53M2.15M1.75M6.88M-70.78M-24.64M
Interest Expense23.36M21.42M53.49M63.78M95.88M208.5M535.72M484.1M
Other Income/Expense-20.61M-39.67M-48.17M-123.67M-106.41M-290.91M-659.29M-523.66M
Pretax Income+35.57M55.46M115.21M-13.62M-3.2M-47.24M-123.25M184.52M
Pretax Margin %0.05%0.06%0.08%-0.01%-0%-0.02%-0.03%0.04%
Income Tax+15.02M17.95M41.23M-8.08M20.36M29.26M89.5M60.06M
Effective Tax Rate %0.62%0.67%0.63%0.54%8.47%1.8%2.04%0.6%
Net Income+21.96M37.04M72.78M-7.32M-27.09M-85.24M-252.04M110.72M
Net Margin %0.03%0.04%0.05%-0%-0.01%-0.03%-0.07%0.03%
Net Income Growth %-0.69%0.96%-1.1%-2.7%-2.15%-1.96%1.44%
Net Income (Continuing)20.55M37.51M73.97M-5.54M-23.56M-76.5M-212.75M124.46M
Discontinued Operations00000000
Minority Interest1.36M15.73M16.54M51.14M50.09M493.08M311.28M145.72M
EPS (Diluted)+0.590.971.69-0.16-0.55-1.90-5.781.63
EPS Growth %-0.64%0.74%-1.09%-2.44%-2.45%-2.04%1.28%
EPS (Basic)0.590.971.69-0.16-0.55-1.90-5.781.64
Diluted Shares Outstanding37.16M37.33M43.01M45.15M47.92M45.04M43.92M67.65M
Basic Shares Outstanding37.16M37.33M43.01M45.15M47.92M45.04M43.92M67.65M
Dividend Payout Ratio-0.27%0.14%----0.01%

Balance Sheet

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+156.01M446.78M441.95M836.18M671.27M1.2B1.55B1.7B
Cash & Short-Term Investments32.5M110.87M36.08M343.45M138.77M208.69M334.26M335.97M
Cash Only32.5M110.87M36.08M343.45M138.77M208.69M241.13M235.75M
Short-Term Investments00000093.13M100.23M
Accounts Receivable69.98M238.12M285.6M370.64M352.66M574.17M860.92M961.89M
Days Sales Outstanding35.5198.5875.390.9865.3885.8581.6879.72
Inventory17.91M31.83M37.06M52.57M61.15M87.58M130.52M143.76M
Days Inventory Outstanding15.222.5115.722017.3519.9318.9418.97
Other Current Assets35.63M65.96M83.21M69.52M118.68M324.66M223.45M262.25M
Total Non-Current Assets+541.23M1.29B1.45B1.81B2.15B5.4B6.14B5.38B
Property, Plant & Equipment451.2M794.64M956.71M1.2B1.35B2.46B2.71B2.41B
Fixed Asset Turnover1.59x1.11x1.45x1.24x1.46x0.99x1.42x1.83x
Goodwill20.59M193.39M188.07M197.71M184.96M1.81B2.07B1.75B
Intangible Assets27.39M238.19M243.53M293.18M325.03M953.03M1.06B902.6M
Long-Term Investments2.44M9.21M9.91M12.1M14.29M13.1M20.87M25.69M
Other Non-Current Assets39.63M57.95M51.14M29.63M163.41M39.88M110.44M89.57M
Total Assets+697.25M1.74B1.89B2.65B2.82B6.59B7.69B7.08B
Asset Turnover1.03x0.51x0.73x0.56x0.70x0.37x0.50x0.62x
Asset Growth %-1.5%0.09%0.4%0.07%1.34%0.17%-0.08%
Total Current Liabilities+254.16M475.57M589.92M566.75M698.49M2.85B1.69B1.95B
Accounts Payable83.38M224.77M230.31M351.25M454.1M512.59M749.35M931.26M
Days Payables Outstanding70.75158.9797.71133.66128.83116.63108.73122.87
Short-Term Debt71.16M109.84M182.16M18.44M29.73M2.04B385.3M654.23M
Deferred Revenue (Current)000446K326K1000K1000K0
Other Current Liabilities62.7M91.17M91.19M131.4M156.06M127.47M205.28M176.61M
Current Ratio0.61x0.94x0.75x1.48x0.96x0.42x0.92x0.88x
Quick Ratio0.54x0.87x0.69x1.38x0.87x0.39x0.84x0.80x
Cash Conversion Cycle-20.04-37.87-6.69-22.67-46.1-10.85-8.11-24.18
Total Non-Current Liabilities+189.66M731.26M722.56M1.43B1.58B2.19B4.22B3.51B
Long-Term Debt108.74M544.87M486.99M1.19B1.32B1.31B3.38B2.97B
Capital Lease Obligations64.56M87.9M151.28M127.52M123.7M134.84M126.18M115.43M
Deferred Tax Liabilities00051.15M53.57M470.16M495.83M0
Other Non-Current Liabilities16.36M98.49M84.29M62.59M78.9M277.25M225.04M431.54M
Total Liabilities443.82M1.21B1.31B2B2.28B5.04B5.91B5.46B
Total Debt+244.71M747.54M848.23M1.35B1.49B3.51B3.92B3.77B
Net Debt212.22M636.67M812.15M1.01B1.35B3.3B3.68B3.53B
Debt / Equity0.97x1.40x1.47x2.08x2.73x2.25x2.21x2.32x
Debt / EBITDA2.84x5.84x3.85x7.67x8.18x9.21x5.09x4.06x
Net Debt / EBITDA2.47x4.98x3.69x5.72x7.42x8.67x4.78x3.81x
Interest Coverage2.41x4.44x3.05x1.73x1.08x1.17x1.00x1.46x
Total Equity+253.43M533.34M578.82M652.07M545.91M1.56B1.78B1.62B
Equity Growth %-1.1%0.09%0.13%-0.16%1.85%0.14%-0.09%
Book Value per Share6.8214.2913.4614.4411.3934.5940.4523.99
Total Shareholders' Equity252.07M517.61M562.28M600.93M495.82M1.06B1.47B1.48B
Common Stock204.36M236.55M236.55M236.55M236.55M236.55M8.82M17.39M
Retained Earnings-58.47M-38.17M17.24M-12.62M-45.49M-90.98M-366.9M-273.53M
Treasury Stock00000000
Accumulated OCI-69.94M-66.81M-77.56M-9.04M-81.28M533.37M1.82B524.78M
Minority Interest1.36M15.73M16.54M51.14M50.09M493.08M311.28M145.72M

Cash Flow

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+95.94M109.3M152.4M156.3M183.34M162.64M582.41M668.5M
Operating CF Margin %0.13%0.12%0.11%0.11%0.09%0.07%0.15%0.15%
Operating CF Growth %-0.14%0.39%0.03%0.17%-0.11%2.58%0.15%
Net Income20.65M36.64M73.87M-5.38M-23.02M-76.83M-214.34M123.96M
Depreciation & Amortization30M32.04M56.75M64.7M77.39M138.09M235.75M219.15M
Stock-Based Compensation0000003.67M9.14M
Deferred Taxes15.09M17.54M41.18M-7.84M19.9M29.38M90.17M59.82M
Other Non-Cash Items27.9M18.76M44.36M102.48M60.05M246.07M607.61M429M
Working Capital Changes2.29M4.32M-63.76M2.34M49.03M-174.07M-140.45M-172.57M
Change in Receivables-12.69M-16.72M-38.61M-6.65M-39.47M-80.48M-316M-343.15M
Change in Inventory-1.01M-527K-6.04M-14.17M-10.78M-22.91M-30.11M-25.85M
Change in Payables00000000
Cash from Investing+-12.78M-580.02M-125.91M-125.93M-291.99M-3.21B-173.15M-236.82M
Capital Expenditures-5.33M-39.01M-104.57M-90.74M-233.25M-102.5M-116.25M-90.86M
CapEx % of Revenue0.01%0.04%0.08%0.06%0.12%0.04%0.03%0.02%
Acquisitions--------
Investments--------
Other Investing-7.44M-7.34M-21.34M-35.44M-54.83M-153.83M61.48M-98.79M
Cash from Financing+-67.08M552.62M-99.47M272.7M-102.13M3.13B-370M-418.12M
Debt Issued (Net)--------
Equity Issued (Net)--------
Dividends Paid0-10M-10M-10.01M0-131K-6.84M-1.15M
Share Repurchases--------
Other Financing-25.15M-31.03M-65.15M-36.79M-105.21M1.22B-671.18M-1.75B
Net Change in Cash--------
Free Cash Flow+90.61M70.29M47.83M27.38M-106.03M10.67M417.25M577.64M
FCF Margin %0.13%0.08%0.03%0.02%-0.05%0%0.11%0.13%
FCF Growth %--0.22%-0.32%-0.43%-4.87%1.1%38.1%0.38%
FCF per Share2.441.881.110.61-2.210.249.508.54
FCF Conversion (FCF/Net Income)4.37x2.95x2.09x-21.36x-6.77x-1.91x-2.31x6.04x
Interest Paid24.2M21.48M37.83M0000450.98M
Taxes Paid00000000

Key Ratios

Metric20172018201920202021202220232024
Return on Equity (ROE)8.67%9.42%13.09%-1.19%-4.52%-8.1%-15.12%6.51%
Return on Invested Capital (ROIC)9.05%8.72%9.57%5.4%4.34%5.41%7.79%10.01%
Gross Margin40.2%41.46%37.86%35.49%34.65%34.28%34.61%37.18%
Net Margin3.05%4.2%5.26%-0.49%-1.38%-3.49%-6.55%2.51%
Debt / Equity0.97x1.40x1.47x2.08x2.73x2.25x2.21x2.32x
Interest Coverage2.41x4.44x3.05x1.73x1.08x1.17x1.00x1.46x
FCF Conversion4.37x2.95x2.09x-21.36x-6.77x-1.91x-2.31x6.04x
Revenue Growth-22.57%57.03%7.4%32.41%23.99%57.6%14.47%

Frequently Asked Questions

Valuation & Price

Auna S.A. (AUNA) has a price-to-earnings (P/E) ratio of 2.8x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Auna S.A. (AUNA) reported $4.22B in revenue for fiscal year 2024. This represents a 486% increase from $719.3M in 2017.

Auna S.A. (AUNA) grew revenue by 14.5% over the past year. This is steady growth.

Yes, Auna S.A. (AUNA) is profitable, generating $182.5M in net income for fiscal year 2024 (2.5% net margin).

Dividend & Returns

Yes, Auna S.A. (AUNA) pays a dividend with a yield of 0.37%. This makes it attractive for income-focused investors.

Auna S.A. (AUNA) has a return on equity (ROE) of 6.5%. This is below average, suggesting room for improvement.

Auna S.A. (AUNA) generated $499.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.